Cargando…
Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes
Recent developments suggest that increased glucagon and decreased somatostatin secretion from the pancreas contribute to hyperglycaemia in type-2 diabetes (T2D) patients. There is a huge need to understand changes in glucagon and somatostatin secretion to develop potential anti-diabetic drugs. To fu...
Autores principales: | Kothegala, Lakshmi, Miranda, Caroline, Singh, Meetu, Krieger, Jean-Philippe, Gandasi, Nikhil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959292/ https://www.ncbi.nlm.nih.gov/pubmed/36834860 http://dx.doi.org/10.3390/ijms24043449 |
Ejemplares similares
-
Setting the Stage for Insulin Granule Dysfunction during Type-1-Diabetes: Is ER Stress the Culprit?
por: Makam, Aishwarya A., et al.
Publicado: (2022) -
Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine–Glutamate Cycle
por: Gandasi, Nikhil R., et al.
Publicado: (2021) -
Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
por: Liguz-Lecznar, Monika, et al.
Publicado: (2022) -
In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis
por: Petrenko, Volodymyr, et al.
Publicado: (2020) -
Somatostatin and Somatostatin-Containing Neurons in Shaping Neuronal Activity and Plasticity
por: Liguz-Lecznar, Monika, et al.
Publicado: (2016)